Anna M. Timofeeva

1.3k total citations · 3 hit papers
45 papers, 813 citations indexed

About

Anna M. Timofeeva is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Anna M. Timofeeva has authored 45 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 17 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Infectious Diseases. Recurrent topics in Anna M. Timofeeva's work include Monoclonal and Polyclonal Antibodies Research (17 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and Glycosylation and Glycoproteins Research (8 papers). Anna M. Timofeeva is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (17 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and Glycosylation and Glycoproteins Research (8 papers). Anna M. Timofeeva collaborates with scholars based in Russia, Australia and Kazakhstan. Anna M. Timofeeva's co-authors include Sergey E. Sedykh, Maria R. Galyamova, Georgy A. Nevinsky, Valentina N. Buneva, Б. М. Доронин, Pavel S. Dmitrenok, Nikita V. Ivanisenko, Nina V. Tikunova, Andrey L. Matveev and Д. Н. Щербаков and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and FEBS Letters.

In The Last Decade

Anna M. Timofeeva

39 papers receiving 792 citations

Hit Papers

Prospects for Using Phosphate-Solubilizing Microorganisms... 2022 2026 2023 2024 2022 2022 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna M. Timofeeva Russia 14 328 288 219 156 68 45 813
Sergey E. Sedykh Russia 14 332 1.0× 496 1.7× 225 1.0× 211 1.4× 71 1.0× 56 1.2k
Huiguang Li China 16 322 1.0× 411 1.4× 54 0.2× 68 0.4× 32 0.5× 25 776
Anna M. Alessi United Kingdom 14 85 0.3× 172 0.6× 39 0.2× 118 0.8× 11 0.2× 25 508
Jennifer R. Town Canada 15 120 0.4× 214 0.7× 16 0.1× 222 1.4× 30 0.4× 40 773
Jinlong Liu China 19 585 1.8× 415 1.4× 47 0.2× 94 0.6× 12 0.2× 56 1.1k
Chaohua Hu China 16 329 1.0× 251 0.9× 20 0.1× 65 0.4× 19 0.3× 28 754
Daniel Uribe-Vélez Colombia 15 374 1.1× 504 1.8× 138 0.6× 16 0.1× 8 0.1× 39 937
Matthew C. Thomas United States 17 108 0.3× 461 1.6× 21 0.1× 229 1.5× 56 0.8× 47 1.0k

Countries citing papers authored by Anna M. Timofeeva

Since Specialization
Citations

This map shows the geographic impact of Anna M. Timofeeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna M. Timofeeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna M. Timofeeva more than expected).

Fields of papers citing papers by Anna M. Timofeeva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna M. Timofeeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna M. Timofeeva. The network helps show where Anna M. Timofeeva may publish in the future.

Co-authorship network of co-authors of Anna M. Timofeeva

This figure shows the co-authorship network connecting the top 25 collaborators of Anna M. Timofeeva. A scholar is included among the top collaborators of Anna M. Timofeeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna M. Timofeeva. Anna M. Timofeeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Timofeeva, Anna M., et al.. (2025). Antibodies Specific to Rheumatologic and Neurologic Pathologies Found in Patient with Long COVID. SHILAP Revista de lepidopterología. 5(1). 1–1. 2 indexed citations
2.
Timofeeva, Anna M., Sergey E. Sedykh, & Georgy A. Nevinsky. (2025). Anti-Idiotypic Antibodies in Immune Regulation and Disease: Therapeutic Promise for Next-Generation Vaccines. Vaccines. 13(12). 1224–1224.
5.
Sedykh, Sergey E., et al.. (2024). Catalase Activity of IgG and κκ-IgG, λλ-IgG, and κλ-IgG Subfractions in HIV-Infected Patients and Healthy Donors. Frontiers in Bioscience-Landmark. 29(5). 191–191.
6.
Timofeeva, Anna M., Maria R. Galyamova, & Sergey E. Sedykh. (2023). Plant Growth-Promoting Bacteria of Soil: Designing of Consortia Beneficial for Crop Production. Microorganisms. 11(12). 2864–2864. 29 indexed citations
8.
Timofeeva, Anna M., Sergey E. Sedykh, Pavel S. Dmitrenok, & Georgy A. Nevinsky. (2023). Identification of Antibody-Mediated Hydrolysis Sites of Oligopeptides Corresponding to the SARS-CoV-2 S-Protein by MALDI-TOF Mass Spectrometry. International Journal of Molecular Sciences. 24(18). 14342–14342. 4 indexed citations
9.
Matveev, Andrey L., Oleg V. Pyankov, Anna M. Timofeeva, et al.. (2023). Novel B-Cell Epitopes of Non-Neutralizing Antibodies in the Receptor-Binding Domain of the SARS-CoV-2 S-Protein with Different Effects on the Severity of COVID-19. Biochemistry (Moscow). 88(9). 1205–1214. 2 indexed citations
10.
Timofeeva, Anna M., et al.. (2023). Milk Exosomes: Next-Generation Agents for Delivery of Anticancer Drugs and Therapeutic Nucleic Acids. International Journal of Molecular Sciences. 24(12). 10194–10194. 38 indexed citations
11.
Kechin, Andrey, et al.. (2022). Do Sputnik V Vaccine-Induced Antibodies Protect Against Seasonal Coronaviruses? Case Study. Viral Immunology. 35(2). 138–141. 1 indexed citations
12.
Sedykh, Sergey E., et al.. (2022). Milk exosomes as delivery agents for therapy of cancer diseases. SHILAP Revista de lepidopterología. 9(2). 23–31.
14.
Timofeeva, Anna M., Sergey E. Sedykh, & Georgy A. Nevinsky. (2022). SARS-CoV-2 infection as a risk factor for the development of autoimmune pathology. 20(5). 3–10. 2 indexed citations
15.
Nevinsky, Georgy A., et al.. (2021). Six catalytic activities and cytotoxicity of immunoglobulin G and secretory immunoglobulin A from human milk. Journal of Dairy Science. 104(6). 6431–6448. 3 indexed citations
16.
Timofeeva, Anna M., et al.. (2021). Very Stable Two Mega Dalton High-Molecular-Mass Multiprotein Complex from Sea Cucumber Eupentacta fraudatrix. Molecules. 26(18). 5703–5703. 2 indexed citations
17.
Timofeeva, Anna M., et al.. (2020). Current possibilities in treating food allergy and food intolerance. 10(1). 53–58. 1 indexed citations
18.
Timofeeva, Anna M., Valentina N. Buneva, & Georgy A. Nevinsky. (2016). Systemic lupus erythematosus: molecular cloning and analysis of recombinant monoclonal kappa light chain NGTA1-Me-pro with two metalloprotease active centers. Molecular BioSystems. 12(12). 3556–3566. 14 indexed citations
19.
Sadeqzadeh, Elham, et al.. (2014). FAT1 cadherin is multiply phosphorylated on its ectodomain but phosphorylation is not catalysed by the four‐jointed homologue. FEBS Letters. 588(18). 3511–3517. 5 indexed citations
20.
Timofeeva, Anna M., et al.. (2009). Affinity and catalytic heterogeneity of polyclonal myelin basic protein‐hydrolyzing IgGs from sera of patients with multiple sclerosis. Journal of Cellular and Molecular Medicine. 14(3). 699–709. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026